University of Minnesota Medical School Researchers Use 3D Technology to Identify Optimal Stem Cells for Transplantation
MINNEAPOLIS, MN- October 4, 2018- Muscular dystrophy is a condition which causes muscle weakness and decreased mobility, caused by defects in a person’s genes. There is no cure. University of Minnesota Medical School researchers have combined technology with science to discover a stem cell population that could hold promising answers for patients in the future.
Skeletal muscle is the most abundant tissue in the body and is composed of several different types of cells including satellite cells. Satellite cells are predominantly responsible for muscle regeneration, during normal day to day activities, as well as during severe muscle diseases like muscular dystrophy.
For many stem cells, such as bone marrow and neural stem cells, for example, the area known as vascular niche has been well studied. However, that has not been the case for muscle stem cells, until now. Atsushi Asakura, PhD, Associate Professor in the Department of Neurology, University of Minnesota Medical School and Mayank Verma, PhD, medical student at the University of Minnesota found a way to study this stem cell niche, as explained in their paper “Muscle Satellite Cell Cross-Talk with a Vascular Niche maintains quiescence via VEGF and Notch Signaling” recently published in Cell Stem Cell.
Verma and Asakura studied the stem cells and blood vessels in large volumes in three dimensions using methods developed in the lab. This is the first time that imaging such as this has been applied so that the interaction between the two populations could be looked at from all different levels in a large number of cells. This showed them that a subset of these stem cells were located close to the blood vessels and were likely to be the more potent stem cell population in the muscles that are maintained in the long run.
“This could be very important for learning more about the role of these stem cells in aging and muscular dystrophy, and treatments in the future,” said Asakura.
The University Imaging Centers were very instrumental in the development of the imaging techniques as well as the analysis of the data which allowed researchers to view the satellite cells and blood vessels in new and groundbreaking ways.
This work was also supported by the Greg Marzolf Jr. Foundation Association Franc¸ aise contre les Myopathies, the National Institutes of Health (T32GM008244, F30AR066454, R01AR062142 and R21AR070319), and the Muscular Dystrophy Association (MDA241600).
About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. Visit med.umn.edu to learn how the University of Minnesota is innovating all aspects of medicine.
Contact: Krystle Barbour
You may also like:
New research by University of Minnesota scientists has revealed the three dimensional structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular dystrophy (FSHD).
A deeper look into meeting the challenges of indigenous dementia in Native American and rural communities.
“It will be the most advanced surgical suite in the world,” said Dr. Chuck Dietz, Chair of the Department of Radiology.